Clinical Trial Update: Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of methoxsalen with extracorporeal photopheresis for pediatric steroid-refractory acute graft-versus-host disease; study terminated with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Steroid-refractory Acute Graft-versus-host Disease

Drugs mentioned

• Extracorporeal Photopheresis
• Methoxsalen (Methoxsalen)

Snippet

Sponsor: Therakos, Inc., a Mallinckrodt Company | Conditions: Steroid Refractory Acute Graft Versus Host Disease | Phase 3 | Status: TERMINATED | Results posted: 2020-09-11